Background: Chronic hepatitis C is an independent risk factor for atherosclerosis and is associated with cardiovascular events. Mechanisms include inflammatory cytokines, endothelial dysfunction, and increased oxidative stress.
Aim Of The Study: The objective was to evaluate the response of carotid atherosclerosis to treatment with direct-antiviral agents.